- Home
- ZEO vs AIFF Comparison
ZEO vs AIFF Comparison
Compare ZEO & AIFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEO
- AIFF
- Stock Information
- Founded
- ZEO 2005
- AIFF 2006
- Country
- ZEO United States
- AIFF Canada
- Employees
- ZEO N/A
- AIFF N/A
- Industry
- ZEO
- AIFF
- Sector
- ZEO
- AIFF
- Exchange
- ZEO NYSE
- AIFF NYSE
- Market Cap
- ZEO 23.0M
- AIFF 26.6M
- IPO Year
- ZEO N/A
- AIFF N/A
- Fundamental
- Price
- ZEO $1.49
- AIFF $3.78
- Analyst Decision
- ZEO
- AIFF
- Analyst Count
- ZEO 0
- AIFF 0
- Target Price
- ZEO N/A
- AIFF N/A
- AVG Volume (30 Days)
- ZEO 12.8K
- AIFF 981.8K
- Earning Date
- ZEO 05-14-2025
- AIFF 05-21-2025
- Dividend Yield
- ZEO N/A
- AIFF N/A
- EPS Growth
- ZEO N/A
- AIFF N/A
- EPS
- ZEO N/A
- AIFF N/A
- Revenue
- ZEO $77,582,314.00
- AIFF $74,000.00
- Revenue This Year
- ZEO N/A
- AIFF N/A
- Revenue Next Year
- ZEO N/A
- AIFF N/A
- P/E Ratio
- ZEO N/A
- AIFF N/A
- Revenue Growth
- ZEO N/A
- AIFF N/A
- 52 Week Low
- ZEO $1.05
- AIFF $1.86
- 52 Week High
- ZEO $5.87
- AIFF $17.20
- Technical
- Relative Strength Index (RSI)
- ZEO 32.69
- AIFF 44.05
- Support Level
- ZEO $1.50
- AIFF $4.47
- Resistance Level
- ZEO $1.79
- AIFF $5.87
- Average True Range (ATR)
- ZEO 0.10
- AIFF 0.70
- MACD
- ZEO 0.01
- AIFF -0.02
- Stochastic Oscillator
- ZEO 3.12
- AIFF 24.45
About ZEO ZEO ENERGY CORP
Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support better outcomes for people suffering from mental illnesses and cognitive disorders.